Altoida, Inc.: Altoida and Ionian University Investigate Breakthrough Software Device for Parkinson's Disease Diagnosis

Partnership will accelerate development of the industry's first predictive device for Alzheimer's Disease to be expanded to diagnosis of Parkinson's disease. Altoida, Inc. the world's leading Precision

Related Keywords

Greece ,Greek ,Kostenloser Wertpapierhandel ,Panagiotis Vlamos ,Henry Peck ,Ioannis Tarnanas ,Altoida Inc ,Health Hub ,Linkedin ,Human Electrophysiology Laboratory Bihelab ,Twitter ,Department Of Informatics At Ionian University ,Alzheimer Drug Discovery Foundation Diagnostics Accelerator ,Precision Neurology ,Human Electrophysiology Laboratory ,Digital Innovation ,Breakthrough Designation ,Drug Discovery Foundation Diagnostics Accelerator ,Chief Scientific Officer ,Professor Panagiotis Vlamos ,Scientific Director ,Computerized Cognitive Assessment Aid ,Eisai Innovation ,Hikma Ventures ,Greysky Venture Partners ,Alpana Ventures ,Altoida ,Exonian ,University ,Investigate ,Breakthrough ,Software ,Device ,Parkinson ,Disease ,Diagnosis ,